Clinical Trials Insight: 700031244
Phase of Trial: Phase I
Latest Information Update: 21 Dec 2009
At a glance
- Drugs LU AA 37096 (Primary)
- Indications Anxiety disorders; Mood disorders
- Focus Adverse reactions
- Sponsors Lundbeck A/S
- 21 Dec 2009 Status changed from recruiting to discontinued.
- 06 Mar 2008 New trial record.